drugset / Trial / NCT07281274

ADO-5030 in Bronchoconstriction Challenge, Phase 1b

NCT07281274 ↗

Phase 1 Not yet recruiting 36 enrolled Adovate University of Virginia · collab
NaSingle-groupOpen-labelTreatment

Summary

This is a Phase 1 study to learn about the safety and pharmacokinetics of the study drug in patients with asthma and whether the study drug has effect during a respiratory challenge.

Timeline

Start
2026-01-01
Primary completion
2026-06-01
Completion
2026-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject ADO-5030 Unknown — Oral

Indications